195 research outputs found

    Dairy Herd Replacement Costs.

    Get PDF
    8 p

    Preliminary results for RR Lyrae stars and Classical Cepheids from the Vista Magellanic Cloud (VMC) Survey

    Get PDF
    The Vista Magellanic Cloud (VMC, PI M.R. Cioni) survey is collecting KSK_S-band time series photometry of the system formed by the two Magellanic Clouds (MC) and the "bridge" that connects them. These data are used to build KSK_S-band light curves of the MC RR Lyrae stars and Classical Cepheids and determine absolute distances and the 3D geometry of the whole system using the KK-band period luminosity (PLKSPLK_S), the period - luminosity - color (PLCPLC) and the Wesenhiet relations applicable to these types of variables. As an example of the survey potential we present results from the VMC observations of two fields centered respectively on the South Ecliptic Pole and the 30 Doradus star forming region of the Large Magellanic Cloud. The VMC KSK_S-band light curves of the RR Lyrae stars in these two regions have very good photometric quality with typical errors for the individual data points in the range of \sim 0.02 to 0.05 mag. The Cepheids have excellent light curves (typical errors of \sim 0.01 mag). The average KSK_S magnitudes derived for both types of variables were used to derive PLKSPLK_S relations that are in general good agreement within the errors with the literature data, and show a smaller scatter than previous studies.Comment: 7 pages, 6 figure. Accepted for publication in Astrophysics and Space Science. Following a presentation at the conference "The Fundamental Cosmic Distance Scale: State of the Art and the Gaia Perspective", Naples, May 201

    Detector Description and Performance for the First Coincidence Observations between LIGO and GEO

    Get PDF
    For 17 days in August and September 2002, the LIGO and GEO interferometer gravitational wave detectors were operated in coincidence to produce their first data for scientific analysis. Although the detectors were still far from their design sensitivity levels, the data can be used to place better upper limits on the flux of gravitational waves incident on the earth than previous direct measurements. This paper describes the instruments and the data in some detail, as a companion to analysis papers based on the first data.Comment: 41 pages, 9 figures 17 Sept 03: author list amended, minor editorial change

    Effect of He implantation on the microstructure of zircaloy-4 studied using in situ TEM

    Get PDF
    Highlights • Differences in the evolution of α and βZr microstructures under 6 keV He ion implantation have been analysed as a function of irradiation dose and temperature using in situ TEM. • Both thermal and irradiation stabilities of Zr hydrides particles were studied and were found to dissolve with increasing fluence. • It is suggested that the combination of two different mass-transport mechanisms for He in zircaloy-4 play a major rule in the Zr hydride irradiation-induced dissolution. • He bubble lattices were observed to form during irradiation at 473 K and 1148 K in both crystalline phases, α and βZr, at around the same fluence of 1.7×10^17 ions⋅cm−2 (3.2 dpa)

    Reforming Watershed Restoration: Science in Need of Application and Applications in Need of Science

    Full text link

    The Global Burden of Cancer 2013

    Get PDF
    IMPORTANCE: Cancer is among the leading causes of death worldwide. Current estimates of cancer burden in individual countries and regions are necessary to inform local cancer control strategies. OBJECTIVE: To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 28 cancers in 188 countries by sex from 1990 to 2013. EVIDENCE REVIEW: The general methodology of the Global Burden of Disease (GBD) 2013 study was used. Cancer registries were the source for cancer incidence data as well as mortality incidence (MI) ratios. Sources for cause of death data include vital registration system data, verbal autopsy studies, and other sources. The MI ratios were used to transform incidence data to mortality estimates and cause of death estimates to incidence estimates. Cancer prevalence was estimated using MI ratios as surrogates for survival data; YLDs were calculated by multiplying prevalence estimates with disability weights, which were derived from population-based surveys; YLLs were computed by multiplying the number of estimated cancer deaths at each age with a reference life expectancy; and DALYs were calculated as the sum of YLDs and YLLs. FINDINGS: In 2013 there were 14.9 million incident cancer cases, 8.2 million deaths, and 196.3 million DALYs. Prostate cancer was the leading cause for cancer incidence (1.4 million) for men and breast cancer for women (1.8 million). Tracheal, bronchus, and lung (TBL) cancer was the leading cause for cancer death in men and women, with 1.6 million deaths. For men, TBL cancer was the leading cause of DALYs (24.9 million). For women, breast cancer was the leading cause of DALYs (13.1 million). Age-standardized incidence rates (ASIRs) per 100 000 and age-standardized death rates (ASDRs) per 100 000 for both sexes in 2013 were higher in developing vs developed countries for stomach cancer (ASIR, 17 vs 14; ASDR, 15 vs 11), liver cancer (ASIR, 15 vs 7; ASDR, 16 vs 7), esophageal cancer (ASIR, 9 vs 4; ASDR, 9 vs 4), cervical cancer (ASIR, 8 vs 5; ASDR, 4 vs 2), lip and oral cavity cancer (ASIR, 7 vs 6; ASDR, 2 vs 2), and nasopharyngeal cancer (ASIR, 1.5 vs 0.4; ASDR, 1.2 vs 0.3). Between 1990 and 2013, ASIRs for all cancers combined (except nonmelanoma skin cancer and Kaposi sarcoma) increased by more than 10 in 113 countries and decreased by more than 10 in 12 of 188 countries. CONCLUSIONS AND RELEVANCE: Cancer poses a major threat to public health worldwide, and incidence rates have increased in most countries since 1990. The trend is a particular threat to developing nations with health systems that are ill-equipped to deal with complex and expensive cancer treatments. The annual update on the Global Burden of Cancer will provide all stakeholders with timely estimates to guide policy efforts in cancer prevention, screening, treatment, and palliation. Copyright 2015 American Medical Association. All rights reserved
    corecore